The primary objective of this study is to assess the potential effectiveness of once daily
application of Valchlor in decreasing disease activity in patients with Lichen Planopilaris.
The primary measurement of efficacy will be with the Lichen Planopilaris Activity Index
(LPPAI) before and after 6 months of treatment. Secondary measures of efficacy will be the
mean follicular density, Physician Global assessment (PGA) score, and the Dermatology Quality
of Life Index (DQLI) score before and after six months of therapy.